Human Lymphocyte Blastogenesis Responses to Mouse Mammary Tumor Virus23
Authors:
- 1 March 1980
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 64 (3) , 425-430
Abstract
Cellular immune responses to antigens associated with mouse mammary tumor virus were evaluated in 101 human female subjects with the use of the lymphocyte blastogenesis assay. Positive responses (stimulation index, >3.0) were seen in 18 of 61 (30%) breast cancer female patients and 2 of 21 (9%) normal female controls. Not only did breast cancer patients respond more frequently but also their stimulation indices were substantially higher than those of the control group. The differences between the two populations had a high degree of statistical significance (Pt-test; PU test). Positive responses were not explainable as nonspecific cross-reactivity because simultaneous tests with Rauscher murine leukemia virus or normal mouse tissue antigens failed to reveal correlating lymphocyte stimulation. Ordinary contact with patients did not appear to influence the frequency of positive cellular responses on the part of normal women. However, female laboratory workers, presumably in contact with mice or mouse viruses, showed frequent reactivity and thus were not considered normal controls. Frequently, reactivity (3/10 subjects) was also seen in a small panel of women with a history of benign breast disease. The study revealed a highly significant association between human breast cancer and in vitro cellular responses to mouse mammary tumor virus, as documented by the lymphocyte blastogenesis assay. Because selected normal populations also showed reactivity, further studies with this technique should be conducted with careful scrutiny of possible environmental, genetic, and clinical correlations among the tested subjects.Keywords
This publication has 11 references indexed in Scilit:
- Detection in human breast carcinomas of an antigen immunologically related to a group-specific antigen of mouse mammary tumor virusProceedings of the National Academy of Sciences, 1978
- CELLULAR IMMUNITY TO AUTOLOGOUS BREAST-CANCER AND RIII-MURINE MAMMARY-TUMOR VIRUS PREPARATIONS1978
- SPECIFICITY OF SIMULTANEOUS CELL-MEDIATED IMMUNE REACTIVITY TO RIII MURINE MAMMARY-TUMOR VIRUS GLYCOPROTEIN 55 AND HUMAN BREAST-CANCER TISSUES1978
- Angiogenesis as a marker of preneoplastic lesions of the human breastCancer, 1978
- Expression of Murine Mammary Tumor Virus-Related Antigens in Human Breast Carcinoma (MCF-7) Cells 2JNCI: Journal of the National Cancer Institute, 1977
- In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stainExperimental Cell Research, 1977
- Interaction between repeated skin testing with recall antigens and temporal fluctuations of in vitro lymphocyte blastogenesis in cancer patientsClinical Immunology and Immunopathology, 1977
- Lymphocyte transformation in vitro to RIII mouse milk antigen among woman with breast diseaseCellular Immunology, 1976
- A Small Virus-Like Particle Observed in Human Breast Cancer by Means of Electron Microscopy2JNCI: Journal of the National Cancer Institute, 1968
- INFECTION OF AN ESTABLISHED MOUSE BONE MARROW CELL LINE (JLS-V9) WITH RAUSCHER AND MOLONEY MURINE LEUKEMIA VIRUSES1967